Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC

Clinical trial NCT06752798 · RECRUITING

Trial details

NCT number: NCT06752798
Sponsor: Hunan Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Carcinoma

Start date: 2024-12-30
Primary completion: 2025-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.